지역약국 약사의 처방중재 활동 평가
Evaluation of Pharmacists’ Intervention Activities in Community Pharmacy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Drug-related problems have the potential to threaten patient health, and pharmacists are in a position to prevent such problems through prescription reviews and patient counseling, actively engaging in pharmaceutical care activities. This study aims to categorize and analyze the intervention activities of pharmacists in community pharmacies concerning drug-related problems, following international criteria. Methods: Over a six-month period, prescription interventions completed in a community pharmacy in Seoul were selected as the research subjects. The causes of interventions were classified according to the Pharmaceutical Care Network Europe (PCNE) drug-related problems (DRPs) classification system and the types and frequencies of DRPs were identified. Results: Among a total of 49,334 prescriptions, 527 interventions were completed, constituting approximately 1.07% of the daily average filled prescriptions. Individuals over 60 years of age represented more than 50%. The primary cause of DRPs was prescribing and drug selection issues, comprising 256 cases (48.58%), with specific subcategories including 109 cases of drug selection, 79 cases of treatment duration errors, 47 cases of dose selection, and 21 cases of inappropriate dosage form selection. Patient-related issues accounted for 204 cases (38.71%). Conclusion: The study demonstrated that the pharmacists’ intervention in community pharmacies contributes to the safe use of medication by patients.
Abstract
Background: Drug-related problems have the potential to threaten patient health, and pharmacists are in a position to prevent such problems through prescription reviews and patient counseling, actively engaging in pharmaceutical care activities. This study aims to categorize and analyze the intervention activities of pharmacists in community pharmacies concerning drug-related problems, following international criteria. Methods: Over a six-month period, prescription interventions completed in a community pharmacy in Seoul were selected as the research subjects. The causes of interventions were classified according to the Pharmaceutical Care Network Europe (PCNE) drug-related problems (DRPs) classification system and the types and frequencies of DRPs were identified. Results: Among a total of 49,334 prescriptions, 527 interventions were completed, constituting approximately 1.07% of the daily average filled prescriptions. Individuals over 60 years of age represented more than 50%. The primary cause of DRPs was prescribing and drug selection issues, comprising 256 cases (48.58%), with specific subcategories including 109 cases of drug selection, 79 cases of treatment duration errors, 47 cases of dose selection, and 21 cases of inappropriate dosage form selection. Patient-related issues accounted for 204 cases (38.71%). Conclusion: The study demonstrated that the pharmacists’ intervention in community pharmacies contributes to the safe use of medication by patients.
참고문헌 (37)
- Mossialos E, "From"retailers"to health care providers : Transforming the role of community pharmacists in chronic disease management", Health Policy, 119(5), pp.628~639 (2015)
- Dalton K, "Role of the pharmacist in reducing healthcare costs : Current insights", Integr Pharm Res Pract, 6, pp.37~46 (2017)
- Lee SY, "A systematic review of outcomes research in the hospital pharmacists’ interventions in south korea", Korean J Clin Pharm, 29(3), pp.193~201 (2019)
- Allemann SS, "Pharmaceutical care : The pcne definition 2013", Int J Clin Pharm, 36, pp.544~555 (2014)
- Hepler CD, "Opportunities and responsibilities in pharmaceutical care", Am J Hosp Pharm, 47(3), pp.533~543 (1990)
- Milosavljevic A, "Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes : A systematic review", Int J Pharm Pract, 26(5), pp.387~397 (2018)
- George PP, "The evolving role of the community pharmacist in chronic disease management-a literature review", Ann Acad Med Singap, 39(11), pp.861~867 (2010)
- Chabot I, "Pharmacist intervention program for control of hypertension", Ann Pharmacother, 37(9), pp.1186~1193 (2003)
- "PCNE V9.1. Classification for Drug related problems V9.1" (2020)[URL]
- Saldanha V, "Risk factors for drug-related problems in a general hospital : A large prospective cohort", PLoS One, 15(5), pp.e0230215~ (2020)
- Plácido AI, "Drug-related problems in home-dwelling older adults : A systematic review", Clin Ther, 42(4), pp.559~572 (2020)
- Al Hamid A, "A systematic review of hospitalization resulting from medicine-related problems in adult patients", Br J Clin Pharmacol, 78(2), pp.202~217 (2014)
- Lampert ML, "Drug-related problems : Evaluation of a classification system in the daily practice of a swiss university hospital", Pharm World Sci, 30, pp.768~776 (2008)
- Liu H, "Drug-related problems in hospitalised parkinson’s disease patients in china", Eur J Hosp Pharm, 29(6), pp.308~312 (2022)
- Kyomya J, "Drug-related problems and associated factors among patients with kidney dysfunction at a tertiary hospital in southwestern uganda : A prospective observational study", BMC Nephrol, 24(1), pp.1~11 (2023)
- Hailu BY, "Drug related problems in admitted geriatric patients : The impact of clinical pharmacist interventions", BMC Geriatr, 20(1), pp.1~8 (2020)
- Kim J-H, "Pharmacist’s intervention activities for drug-related problems in a community pharmacy", Yakhak Hoeji, 67(2), pp.128~136 (2023)
- Won CW, "Korean frailty and aging cohort study(kfacs) : Cohort profile", BMJ Open, 10(4), pp.e035573~ (2020)
- Viktil KK, "Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems", Br J Clin Pharmacol, 63(2), pp.187~195 (2007)
- Díez R, "Drug-related problems and polypharmacy in nursing home residents : A cross-sectional study", Int J Environ Res Public Health, 19(7), pp.4313~ (2022)
- Kim MG, "Gap between patient expectation and perception during pharmacist-patient communication at community pharmacy", Int J Clin Pharm, 42, pp.677~684 (2020)
- Sell R, "Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews", Int J Clin Pharm, 42, pp.588~597 (2020)
- Hügl B, "Clinical significance of the rivaroxaban-dronedarone interaction : Insights from physiologically based pharmacokinetic modelling", Eur Heart J Open, 3(1), pp.oead004~ (2023)
- Wang Y, "Suggestions for pharmacists’ intervention according to analysis of prescription practices of contraindicated drug-drug interaction", Journal of Korean Society of Health-System Pharmacists, 38(3), pp.291~305 (2021)
- Boriani G, "Safety and efficacy of dronedarone from clinical trials to real-world evidence : Implications for its use in atrial fibrillation", Europace, 21(12), pp.1764~1775 (2019)
- Choi HE, "Use of sglt2 inhibitor", metformin fixed dose combination in korea, 2022, pp.32(1), 13~19
- Chang CT, "Development of a malaysian potentially inappropriate prescribing screening tool in older adults(malpip) : A delphi study", J Pharm Policy Pract, 16(1), pp.122~ (2023)
- Poyurovsky M, "Treatment of antipsychotic-induced akathisia : Role of serotonin 5-ht 2a receptor antagonists", Drugs, 80, pp.871~882 (2020)
- Elsey JW, "Reconsolidation-based treatment for fear of public speaking : A systematic pilot study using propranolol", Transl Psychiatry, 10(1), pp.179~ (2020)
- Huang K-Y, "Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials", Sci Rep, 11(1), pp.452~ (2021)
- Koo H, "Class duplication prescriptions in patients taking fixed-dose combination antihypertensives", Korean J Clin Pharm, 32(2), pp.125~132 (2022)
- Jang H-M, "Impact and barriers of the health insurance review on splitting extended-release formulation drugs", Korean J Clin Pharm, 21(4), pp.347~352 (2011)
- Shariff ZB, "Does the formulation of oral solid dosage forms affect acceptance and adherence in older patients? A mixed methods systematic review", J Am Med Dir Assoc, 21(8), pp.1015~1023 (2020)
- Anderson LJ, "A systematic overview of systematic reviews evaluating medication adherence interventions", Am J Health Syst Pharm, 77(2), pp.138~147 (2020)
- Schindler E, "Pharmaceutical care network europe(pcne)drug-related problem classification version 9. 00 : German translation and validation", Int J Clin Pharm, 43, pp.726~730 (2021)
- Garin N, "Drug related problems in clinical practice : A cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions", Sci Rep, 11(1), pp.883~ (2021)